Scientists make anti-cancer compounds
Washington, Feb 13 (IANS) Yale University scientists have streamlined the process for synthesising a family of compounds that can potentially kill cancer and other diseased cells, representing a unique category of anti-cancer agents.
Read more on MalaysiaNews.net
In this study, a team led by Gosse J. Adema, Ph.D., of the Department of Tumor Immunology, at the Radboud University Nijmegen Medical Centre, the Netherlands, and colleagues assessed the role of DC-SCRIPT as a co-regulator of nuclear receptors, including estrogen receptor (ER), progesterone receptor (PR)-B, peroxisome proliferator-activated receptor gamma, and retinoic acid receptor alpha. Prognostic value was assessed in three independent cohorts of breast cancer patients.
The researchers found that DC-SCRIPT suppressed ER- and PR-mediated transcription in a ligand-dependent fashion, whereas it enhanced the activity of the other two receptors. Quantification of DC-SCRIPT mRNA expression in the three cohorts of patients revealed that this expression is an independent prognostic factor for breast cancer patients with ER- and/or PR-positive tumors, according to the authors.
» Read more: DC-SCRIPT Found to Have Prognostic Value in Breast Cancer
Cancer linked to our food
AN alarming US cancer report calls for the removal of toxins from food and water, warning the risk from chemicals was underestimated.
Read more on Herald Sun